We are live on ! Find out more
EA

Emerald Acquisition Portfolio holdings

AUM $51.8B
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$57.7B
AUM Growth
Cap. Flow
+$57.1B
Cap. Flow %
98.97%
Top 10 Hldgs %
10.09%
Holding
2,993
New
2,993
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$755M
2
MSFT icon
Microsoft
MSFT
+$711M
3
WFC icon
Wells Fargo
WFC
+$630M
4
TSM icon
TSMC
TSM
+$575M
5
JPM icon
JPMorgan Chase
JPM
+$549M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 17.76%
2 Healthcare 12.74%
3 Technology 11.3%
4 Industrials 10.13%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGND
2401
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
$525K ﹤0.01%
+13,330
New +$446K
JMP
2402
DELISTED
JMP Group LLC
JMP
$524K ﹤0.01%
+96,429
New +$510K
CTBI icon
2403
Community Trust Bancorp
CTBI
$1.36B
$522K ﹤0.01%
+15,070
New +$534K
BT
2404
DELISTED
BT Group plc (ADR)
BT
$521K ﹤0.01%
+18,721
New +$588K
CMCM
2405
Cheetah Mobile
CMCM
$89.4M
$520K ﹤0.01%
+10,949
New +$718K
WST icon
2406
West Pharmaceutical
WST
$25.1B
$520K ﹤0.01%
+6,855
New +$499K
S
2407
DELISTED
Sprint Corporation
S
$520K ﹤0.01%
+114,905
New +$425K
BGS icon
2408
B&G Foods
BGS
$285M
$518K ﹤0.01%
+10,749
New +$438K
BUFF
2409
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$516K ﹤0.01%
+22,156
New +$551K
PCRX icon
2410
Pacira BioSciences
PCRX
$1.02B
$515K ﹤0.01%
+15,273
New +$751K
LQDT icon
2411
Liquidity Services
LQDT
$1.17B
$508K ﹤0.01%
+64,744
New +$409K
TRUE
2412
DELISTED
TrueCar
TRUE
$508K ﹤0.01%
+64,660
New +$429K
CRAY
2413
DELISTED
Cray, Inc.
CRAY
$504K ﹤0.01%
+16,842
New +$590K
CVCO icon
2414
Cavco Industries
CVCO
$4.33B
$501K ﹤0.01%
+5,346
New +$493K
NVRI icon
2415
Enviri
NVRI
$633M
$501K ﹤0.01%
+75,500
New +$492K
EMCI
2416
DELISTED
EMC INS Group Inc
EMCI
$501K ﹤0.01%
+18,099
New +$479K
CTRL
2417
DELISTED
Control4 Corporation
CTRL
$501K ﹤0.01%
+61,347
New +$475K
ACRS icon
2418
Aclaris Therapeutics
ACRS
$765M
$500K ﹤0.01%
+27,096
New +$537K
ALR
2419
DELISTED
AlerisLife Inc
ALR
$500K ﹤0.01%
+21,372
New +$461K
PHH
2420
DELISTED
PHH Corporation
PHH
$499K ﹤0.01%
+37,436
New +$485K
SRPT icon
2421
Sarepta Therapeutics
SRPT
$1.68B
$496K ﹤0.01%
+26,004
New +$482K
ESLT icon
2422
Elbit Systems
ESLT
$37.9B
$495K ﹤0.01%
+5,464
New +$520K
NUS icon
2423
Nu Skin
NUS
$247M
$494K ﹤0.01%
+10,734
New +$432K
WFBI
2424
DELISTED
WashingtonFirst Bankshares Inc
WFBI
$494K ﹤0.01%
+23,985
New +$498K
ITG
2425
DELISTED
Investment Technology Group Inc
ITG
$493K ﹤0.01%
+29,500
New +$553K

Similar funds

Emerald Acquisition's Q2 2016 Portfolio in Review

Q2 2016 is the first quarter with a 13F filing on record for Emerald Acquisition, which disclosed 2,993 positions worth $57.7B. Its ten largest holdings account for 10% of the portfolio.

Its largest position is Johnson & Johnson: 6,642,592 shares worth $805M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, followed by Healthcare and Technology.

  • Emerald Acquisition's largest Q2 2016 buy was Johnson & Johnson: 6,642,592 shares worth $805M.
  • Emerald Acquisition's ten largest holdings make up 10% of its $57.7B portfolio in Q2 2016.
  • Emerald Acquisition disclosed 2,993 positions in Q2 2016, its first 13F filing on record.

Based on Emerald Acquisition's 13F filing for Q2 2016, filed 3 Aug 2016.